share_log

Ladenburg Thalmann Upgrades Forte Biosciences to Buy, Announces $2.75 Price Target

Ladenburg Thalmann Upgrades Forte Biosciences to Buy, Announces $2.75 Price Target

拉登堡塔尔曼将Forte Biosciences上调至收购,宣布2.75美元的目标股价
Benzinga ·  04/08 17:36

Ladenburg Thalmann analyst Michael Higgins upgrades Forte Biosciences (NASDAQ:FBRX) from Neutral to Buy and announces $2.75 price target.

拉登堡塔尔曼分析师迈克尔·希金斯将Forte Biosciences(纳斯达克股票代码:FBRX)从中性上调至买入,并宣布了2.75美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发